|
Volumn 12, Issue 9, 2006, Pages 922-923
|
Are COX-2 inhibiotrs safe for anyone
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ETORICOXIB;
IMMUNOMODULATING AGENT;
MESALAZINE;
NABUMETONE;
NAPROXEN;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PROSTAGLANDIN SYNTHASE;
PLACEBO;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DIGESTIVE SYSTEM ULCER;
DISEASE EXACERBATION;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG SAFETY;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL TOXICITY;
HUMAN;
NOTE;
PRIORITY JOURNAL;
REMISSION;
ULCERATIVE COLITIS;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
PILOT STUDY;
RANDOMIZED CONTROLLED TRIAL;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
COLITIS, ULCERATIVE;
CYCLOOXYGENASE 2 INHIBITORS;
HUMANS;
PILOT PROJECTS;
PLACEBOS;
PYRAZOLES;
SULFONAMIDES;
|
EID: 33748461582
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1002/ibd.3780120913 Document Type: Note |
Times cited : (1)
|
References (0)
|